FDA approves Neuralstem's stem cell trial

09/21/2009 | Chicago Tribune (tiered subscription model)

Neuralstem has received FDA approval to test the safety of injecting neural stem cells into the spinal cords of patients with amyotrophic lateral sclerosis, or Lou Gehrig's disease. Dr. Eva Feldman, a University of Michigan neurologist, will serve as the principal investigator of the clinical trial, which will be conducted at Emory University in Atlanta.

View Full Article in:

Chicago Tribune (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC